Quick Answer
Corvus Pharmaceuticals, Inc. reported Total Assets of $71.12 million for fiscal year 2025.
Corvus Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $71.12M | +3.2% |
| 2024 | $68.91M | +51.3% |
| 2023 | $45.55M | -33.2% |
| 2022 | $68.24M | -37.7% |
| 2021 | $109.45M | +28.0% |
| 2020 | $85.53M | +2.3% |
| 2019 | $83.65M | -29.3% |
| 2018 | $118.23M | +24.8% |
| 2017 | $94.78M | -32.4% |
| 2016 | $140.15M | +42.3% |
| 2015 | $98.46M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $80.47M | +36.8% | -10.0% |
| June 30, 2025 | $89.46M | +38.6% | +50.5% |
| March 31, 2025 | $59.44M | +48.3% | -13.7% |
| December 31, 2024 | $68.91M | +51.3% | +17.2% |
| September 30, 2024 | $58.81M | +13.2% | -8.9% |
| June 30, 2024 | $64.56M | +11.2% | +61.1% |
| March 31, 2024 | $40.08M | -31.1% | -12.0% |
| December 31, 2023 | $45.55M | -33.2% | -12.3% |
- Corvus Pharmaceuticals, Inc. showed an increase of +3.2% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Corvus Pharmaceuticals, Inc.’s total assets has declined by 27.8% (from $98.46 million to $71.12 million).
- The most recent figure is from Corvus Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: